MedTrace Logo

Safety and Efficacy of Hair Stimulating Complex (HSC) on Hair Growth in Males With Androgenetic Alopecia

NCT01501617 · Status: UNKNOWN · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 56

Last updated 2012-01-18

No results posted yet for this study

Summary

The purpose of this study is to evaluate the safety and efficacy in relation to dosing in the administration of Hair Stimulating Complex (HSC) in healthy men. HSC will be injected intradermally in the scalps of men with male pattern baldness (i.e. androgenetic alopecia).

Conditions

Interventions

BIOLOGICAL

Hair Stimulating Complex (HSC)

Study preparation (experimental) of 0.8 mL will be injected intradermally at Baseline and Week 6.

DEVICE

Dulbecco's Modified Eagle Medium, DMEM

Study preparation (placebo comparator) of 0.8 mL will be injected intradermally at Baseline and Week 6.

Sponsors & Collaborators

  • Gleneagles CRC Pte Ltd.

    collaborator UNKNOWN

  • Histogen

    lead INDUSTRY

Principal Investigators

  • Theresa Marie Reyes-Cacas, MD · The Medical City

  • Julieta P. Arambulo, MD · The Medical City

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE

Eligibility

Min Age
21 Years
Max Age
65 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-12-31
Primary Completion
2012-06-30
Completion
2012-12-31

Countries

  • Philippines

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01501617 on ClinicalTrials.gov